Berry Genomics Co.,Ltd Stock

Equities

000710

CNE000000PN7

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
8.1 CNY +10.05% Intraday chart for Berry Genomics Co.,Ltd +8.87% -29.69%
Sales 2022 1.37B 189M Sales 2023 1.15B 159M Capitalization 4.07B 563M
Net income 2022 -255M -35.23M Net income 2023 -427M -58.99M EV / Sales 2022 2.96 x
Net Debt 2022 10.11M 1.4M Net cash position 2023 48.43M 6.69M EV / Sales 2023 3.49 x
P/E ratio 2022
-13.9 x
P/E ratio 2023
-9.52 x
Employees 1,438
Yield 2022 *
-
Yield 2023
-
Free-Float 60.19%
More Fundamentals * Assessed data
Dynamic Chart
1 day+10.05%
1 week+8.87%
Current month-14.29%
1 month-22.12%
3 months-19.56%
6 months-15.71%
Current year-29.69%
More quotes
1 week
6.88
Extreme 6.88
8.10
1 month
6.72
Extreme 6.72
9.91
Current year
5.40
Extreme 5.4
13.16
1 year
5.40
Extreme 5.4
16.48
3 years
5.40
Extreme 5.4
36.37
5 years
5.40
Extreme 5.4
98.00
10 years
5.40
Extreme 5.4
98.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 97-04-13
Director of Finance/CFO 51 17-07-19
Chief Administrative Officer 38 20-08-06
Members of the board TitleAgeSince
Chief Executive Officer 44 97-04-13
48 -
Director of Finance/CFO 51 17-07-19
More insiders
Date Price Change Volume
24-04-25 8.1 +10.05% 10,040,090
24-04-24 7.36 +0.14% 9,249,201
24-04-23 7.35 +4.70% 11,695,900
24-04-22 7.02 -2.09% 8,166,400
24-04-19 7.17 -3.63% 11,501,500

End-of-day quote Shenzhen S.E., April 24, 2024

More quotes
Berry Genomics Co Ltd is a company mainly engaged in medical testing related services. The Company's business is comprised of basic scientific research services, medical testing services, testing reagent sales and testing equipment sales. The basic scientific research services business provides the clients with multiple sequencing platforms for testing projects, such as transcriptome sequencing, human whole exome sequencing and whole genome sequencing. The medical testing services business include tumor genetic testing services, genetic disease genetic testing services and reproductive health testing services. The Company sells a range of reagents and equipment, including NextSeq CN500 gene sequencer and general reagents for sequencing reactions.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000710 Stock